Document is current
Any future updates will be listed below
-
Authors
Kawano, Fumihiro
Lim, Megan A.
Kemprecos, Helen J.
Tsai, Kathryn
Cheah, Daniel
Tigranyan, Annie
Kaviamuthan, Kanakaraju
Pillai, Arundhati
Chen, Jaime
Polites, Gregory
Brummett, Tim
Solai, Killivalavan
Bellini, Michel
Mise, Yoshihiro
Leite, Leandro
Cohen, Mark
Saiura, Akio
Conrad, Claudius
- License Information
-
More Information
Article History
Received: 19 June 2025
Accepted: 24 July 2025
First Online: 6 September 2025
Disclosure
: Mark Cohen reports being co-founder with equity share (no revenues generated—preclinical) of REGENDO Corporation, Hylamend LLC, and Ferroximend LLC; as well as having an advisor position (with equity, no revenues generated) at GigXR, Inc position with equity.
